Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 1,71 k
0,05%0,11%34.2x6.17x8.53x26.72x27.15x 55,63 Md
1,52%1,77%19.78x3.77x6x13.04x15.21x 52,25 Md
-.--%-.--%-18.16x1.12x4.33x-7.56x-6.2x 23,07 Md
-.--%-.--%-39.15x52.52x12.94x-37.74x-40.61x 22,41 Md
-.--%-.--%21.62x2.12x4.23x10.97x13.2x 17,32 Md
-.--%-.--%22.36x2.56x4.48x14.84x16.67x 15,94 Md
-.--%0,13%44.46x10.61x16.86x51x42.75x 13,47 Md
-.--%-.--%17.25x4.91x5x11.74x12.79x 13,77 Md
-.--%-.--%-436.4x17.91x29.85x-3327.81x-326.7x 12,43 Md
-.--%-.--%-74.63x26.29x7.55x-67.7x-55.06x 11,82 Md
-.--%-.--%-24.99x25.66x22.81x-29.28x-23.69x 11,11 Md
-.--%-.--%-12.51x147.23x3254.69x-15.14x-12.36x 10,87 Md
-.--%-.--%-12.71x-52.68x97.46x-14.44x-14.06x 11,16 Md
-.--%0,03%1803.77x6.92x12.05x77.02x259.41x 9,78 Md
-.--%-.--%-21.54x8.26x797.8x-18.72x-18.63x 9,76 Md
-.--%-.--%10.32x4.94x6.98x11.3x11.94x 7,72 Md
-.--%-.--%-6.64x - - -6.81x-6.26x 8,16 Md
Moyenne 0,09% 0,12% 78,06x 16,77x 268,22x -194,62x -6,14x 17,04 Md
Moyenne pondérée par Capi. 0,27% 0,33% 45,03x 13,56x 156,67x -129,74x -1,21x
Médicaments bio-thérapeutiques